Linderone

CAS No. 1782-79-2

Linderone( —— )

Catalog No. M37737 CAS No. 1782-79-2

Linderone, a compound isolated from Lindera erythrocarpa, has antioxidant and anti-inflammatory activity and can be used to study neuroinflammation.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 1205 Get Quote
2MG 540 Get Quote
5MG 758 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Linderone
  • Note
    Research use only, not for human use.
  • Brief Description
    Linderone, a compound isolated from Lindera erythrocarpa, has antioxidant and anti-inflammatory activity and can be used to study neuroinflammation.
  • Description
    Linderone is an antioxidant agent.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Antioxidant
  • Recptor
    Antioxidant
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1782-79-2
  • Formula Weight
    286.28
  • Molecular Formula
    C16H14O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(/C=C/C1=CC=CC=C1)(=O)C2C(=O)C(OC)=C(OC)C2=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Mwadham M. Kabanda, et al. Conformational, electronic and antioxidant properties of lucidone, linderone and methyllinderone: DFT, QTAIM and NBO studies.
molnova catalog
related products
  • mogroside Ive

    Mogroside IV-E is a triterpenoid glycoside isolated from the extracts of Luo Han Guo. Mogrosides exhibit antidiabetic antioxidant and anticancer activities.

  • Methyl-β-cyclodextri...

    Methyl-β-cyclodextrin, a cyclic heptasaccharide, is an effective agent for the depletion of cholesterol from cells; also inhibits PEL cell growth with an IC50 of 3.33-4.23 mM.

  • BMY-21502

    BMY-21502 is a potential cognitive enhancer that shows anti-hypoxia effects in the KCN-hypoxia model, delays the decay of hippocampal synaptic enhancement in vitro, and can be used to study Alzheimer's disease.